Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Galapagos acquires GSK research center in Croatia
October 2010
SHARING OPTIONS:

ZAGREB, Croatia—In early September, Galapagos NV announced its acquisition of a state-of-the-art antibacterial research center operated here by GlaxoSmithKline PLC (GSK). Terms of the deal include the acquisition of the center along with the transfer of approximately 130 staff. In addition, Galapagos will provide R&D services to GSK under a three-year, fee-for-service contract valued at $18.2 million. The site will form the basis of a newly created third Galapagos business unit called Internal Outsourcing, allowing Galapagos to resource research programs from molecule through to the clinic in alignment with its milestone-driven alliance model.   "The team in Zagreb brings a proven track record and expertise in disease and discovery development that matches that of our current pharmaceutical alliances," says Onno van de Stolpe, CEO of Galapagos. "The acquisition answers our expansion needs and, by bringing a majority of our outsourced programs back in house, we can achieve significant cost savings in R&D."  

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.